AIHealthcare Analytics

Overview

Helio Genomics is an AI-driven genomics company focused on early cancer detection and genomic analysis. The company expanded its board in 2026 with the addition of a prominent healthcare AI leader.

Board Appointment

Parminder Bhatia, described as a Healthcare AI Leader, joined the Helio Genomics Board of Directors (article 5). Bhatia's background in healthcare AI is expected to accelerate Helio's integration of AI capabilities into its genomics platform and strengthen its position in the clinical AI market.

Platform Focus

Helio Genomics applies AI to genomic data for applications including liquid biopsy-based cancer detection, biomarker identification, and personalized medicine. The intersection of AI and genomics is a high-growth area attracting significant investment and regulatory attention.